Genetic variants in LGALS3 are related to lower galectin-3 serum levels and clinical outcomes in systemic sclerosis patients: A case-control study

References

• Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;6736(17):1–15.
   Google Scholar
• Allanore Y, Simms R, Distler O, et al. Systemic sclerosis. Nat Rev Dis Prim. 2015;1:15002.
   PubMed Web of Science ®Google Scholar
• Horimoto AMC, Matos ENN, da Costa MR, et al. Incidência e prevalência de esclerose sistêmica em Campo Grande, Estado de Mato Grosso do Sul. Brasil. Rev Bras Reumatol. 2017;57(2):107–114.
   PubMedGoogle Scholar
• Elhai M, Avouac J, Walker UA, EUSTAR co-authors, et al. A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study. Ann Rheum Dis. 2016;75(1):163–169.
   PubMed Web of Science ®Google Scholar
• Ranque B, Mouthon L. Geoepidemiology of systemic sclerosis. Autoimmun Rev. 2010;9(5):A311–A318.
   PubMed Web of Science ®Google Scholar
• Karassa FB, Ioannidis JPA. Mortality in systemic sclerosis. Clin Exp Rheumatol. 2008;26(5 SUPPL. 51):131–137.
   Web of Science ®Google Scholar
• Nikpour M, Baron M. Mortality in systemic sclerosis: lessons learned from population-based and observational cohort studies. Curr Opin Rheumatol. 2014;26(2):131–137.
   PubMed Web of Science ®Google Scholar
• Ho YY, Lagares D, Tager AM, et al. Fibrosis—a lethal component of systemic sclerosis. Nat Rev Rheumatol. 2014;10(7):390–402.
   PubMed Web of Science ®Google Scholar
• Elhai M, Meune C, Boubaya M, et al. Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis. 2017;76(11):1897–1905.
   PubMed Web of Science ®Google Scholar
• Sakkas LI. New developments in the pathogenesis of systemic sclerosis. Autoimmunity. 2005;38(2):113–116.
   PubMed Web of Science ®Google Scholar
• Taniguchi T, Asano Y, Akamata K, et al. Serum levels of galectin-3: possible association with fibrosis, aberrant angiogenesis, and immune activation in patients with systemic sclerosis. J Rheumatol. 2012;39(3):539–544.
   PubMed Web of Science ®Google Scholar
• Faludi R, Nagy G, Tőkés-Füzesi M, et al. Galectin-3 is an independent predictor of survival in systemic sclerosis. Int J Cardiol. 2017;233:118–124.
   PubMed Web of Science ®Google Scholar
• Koca SS, Akbas F, Ozgen M, et al. Serum galectin-3 level in systemic sclerosis. Clin Rheumatol. 2014;33(2):215–220.
   PubMed Web of Science ®Google Scholar
• de Oliveira FL, Gatto M, Bassi N, et al. Galectin-3 in autoimmunity and autoimmune diseases. Exp Biol Med. 2015;240(8):1019–1028.
   PubMed Web of Science ®Google Scholar
• Wan L, Liu F-T. Galectin-3 and inflammation. Glycobiol Insights. 2016;6:1.
   Google Scholar
• Henderson NC, Sethi T. The regulation of inflammation by galectin-3. Immunol Rev. 2009;230(1):160–171.
   PubMed Web of Science ®Google Scholar
• Kadrofske MM, Openo KP, Wang JL. The human LGALS3 (galectin-3) gene: Determination of the gene structure and functional characterization of the promoter. Arch Biochem Biophys. 1998;349(1):7–20.
   PubMed Web of Science ®Google Scholar
• Hirabayashi J, Kasai K. The family of metazoan metal-independent beta-galactoside-binding lectins: structure, function and molecular evolution. Glycobiology. 1993;3(4):297–304.
   PubMed Web of Science ®Google Scholar
• Kaur T, Thakur K, Singh J, et al. Identification of functional SNPs in human LGALS3 gene by in silico analyses. Egypt J Med Hum Genet. 2017;18(4):321–328.
   Google Scholar
• Barondes SH, Cooper DNW, Gitt MA, et al. Structure and function of a large family of animal lectins. J Biol Chem. 1994;269(33):20807–20810.
   PubMed Web of Science ®Google Scholar
• Dumic J, Dabelic S, Flögel M. Galectin-3: An open-ended story. Biochim Biophys Acta Gen Subj. 2006;1760(4):616–635.
   PubMed Web of Science ®Google Scholar
• Rabinovich GA, Toscano MA, Jackson SS, et al. Functions of cell surface galectin-glycoprotein lattices. Curr Opin Struct Biol. 2007;17(5):513–520.
   PubMed Web of Science ®Google Scholar
• Fukumori T, Takenaka Y, Oka N, et al. Endogenous galectin-3 determines the routing of CD95 apoptotic signaling pathways. Cancer Res. 2004;64(10):3376–3379.
   PubMed Web of Science ®Google Scholar
• Hsu DK, Yang RY, Saegusa J, et al. Analysis of the intracellular role of galectins in cell growth and apoptosis. Methods Mol Biol. 2015;1207:451–463.
   PubMedGoogle Scholar
• Dagher SF, Wang JL, Patterson RJ. Identification of galectin-3 as a factor in pre-mRNA splicing. Proc Natl Acad Sci USA. 1995;92(4):1213–1217.
   PubMed Web of Science ®Google Scholar
• Ochieng J, Furtak V, Lukyanov P. Extracellular functions of galectin-3. Glycoconj J. 2002;19(7–9):527–535.
   PubMed Web of Science ®Google Scholar
• Liu FT, Rabinovich GA. Galectins: regulators of acute and chronic inflammation. Ann NY Acad Sci. 2010;1183(1):158–182.
   PubMedGoogle Scholar
• Chung AW, Sieling PA, Schenk M, et al. Galectin-3 regulates the innate immune response of human monocytes. J Infect Dis. 2013;207(6):947–956.
   PubMed Web of Science ®Google Scholar
• Rabinovich GA, Toscano MA. Turning ‘sweet’ on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat Rev Immunol. 2009;9(5):338–352.
   PubMed Web of Science ®Google Scholar
• Karlsson A, Christenson K, Matlak M, et al. Galectin-3 functions as an opsonin and enhances the macrophage clearance of apoptotic neutrophils. Glycobiology. 2008;19(1):16–20.
   PubMed Web of Science ®Google Scholar
• Hsu DK, Chen HY, Liu FT. Galectin-3 regulates T-cell functions. Immunol Rev. 2009;230(1):114–127.
   PubMed Web of Science ®Google Scholar
• Sato S, St-Pierre C, Bhaumik P, et al. Galectins in innate immunity: Dual functions of host soluble β-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs). Immunol Rev. 2009;230(1):172–187.
   PubMedGoogle Scholar
• Henderson NC, Mackinnon AC, Farnworth SL, et al. Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci USA. 2006;103(13):5060–5065.
   PubMed Web of Science ®Google Scholar
• Trompet S, Jukema W, Mooijaart SP, et al. Genetic variation in galectin-3 gene associates with cognitive function at old age. Neurobiol Aging. 2012;33(9):2232.e1-2232–e9.
   Web of Science ®Google Scholar
• Hu CY, Chang SK, Wu CS, et al. Galectin-3 gene (LGALS3) +292C allele is a genetic predisposition factor for rheumatoid arthritis in Taiwan. Clin Rheumatol. 2011;30(9):1227–1233.
   PubMed Web of Science ®Google Scholar
• Cruz GS, Angelo ALD, Larocca TF, et al. Assessment of galectin-3 polymorphism in subjects with chronic Chagas disease. Arq Bras Cardiol. 2015;105(5):472–478.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang Y, Zhai M, et al. Influence of LGALS3 gene polymorphisms on susceptibility and prognosis of dilated cardiomyopathy in a Northern Han Chinese population. Gene. 2018;642:293–298.
   PubMed Web of Science ®Google Scholar
• Kaur T, Thakur K, Singh J, et al. Genotypic-phenotypic screening of galectin-3 in relation to risk towards rheumatoid arthritis in North Indian population. Arch Med Res. 2019;50(4):214–224.
   PubMed Web of Science ®Google Scholar
• Atabaki M, Hashemi M, Daneshvar H, et al. Lectin, galactoside-binding, soluble, 3 rs4652 A/C gene variation and the risk for rheumatoid arthritis. Biomed Reports. 2017;6(2):251–255.
   PubMed Web of Science ®Google Scholar
• Kaur T, Sodhi A, Singh J, et al. Evaluation of galectin-3 genetic variants and its serum levels in rheumatoid arthritis in North India. Int J Hum Genet. 2015;15(3):131–138.
   Web of Science ®Google Scholar
• De Belmont TFM, Do ÓK, Da Silva AS, et al. Single nucleotide polymorphisms at +191 and +292 of galectin-3 gene (LGALS3) related to lower GAL-3 serum levels are associated with frequent respiratory tract infection and vaso-occlusive crisis in children with sickle cell Anemia. PLOS One. 2016;11(9):1–13.
   Web of Science ®Google Scholar
• Van Den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an american college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum. 2013;65(11):2737–2747.
   PubMed Web of Science ®Google Scholar
• Davis LG, Dibner MD, Battey JF. Basic methods in molecular biology: DNA/RNA extraction and precipitation. New York, NY: Elsevier; 1986.
   Google Scholar
• Firestein GS, McInnes IB. Immunopathogenesis of rheumatoid arthritis. Immunity. 2017;46(2):183–196.
   PubMed Web of Science ®Google Scholar
• Japp AG, Gulati A, Cook SA, et al. The diagnosis and evaluation of dilated cardiomyopathy. J Am Coll Cardiol. 2016;67(25):2996–3010.
   PubMed Web of Science ®Google Scholar
• Hromádka M, Seidlerová J, Suchý D, et al. Myocardial fibrosis detected by magnetic resonance in systemic sclerosis patients – relationship with biochemical and echocardiography parameters. Int J Cardiol. 2017;249:448–453.
   PubMed Web of Science ®Google Scholar
• Menon RP, Hughes RC. Determinants in the N-terminal domains of galectin-3 for secretion by a novel pathway circumventing the endoplasmic reticulum-Golgi complex. Eur J Biochem. 1999;264(2):569–576.
   PubMedGoogle Scholar
• Schneider D, Greb C, Koch A, et al. Trafficking of galectin-3 through endosomal organelles of polarized and non-polarized cells. Eur J Cell Biol. 2010;89(11):788–798.
   PubMed Web of Science ®Google Scholar
• Hu Y, Yéléhé-Okouma M, Ea HK, et al. Galectin-3: a key player in arthritis. Jt Bone Spine. 2017;84(1):15–20.
   PubMed Web of Science ®Google Scholar
• Menon S, Kang CM, Beningo KA. Galectin-3 secretion and tyrosine phosphorylation is dependent on the calpain small subunit, Calpain 4. Biochem Biophys Res Commun. 2011;410(1):91–96.
   PubMed Web of Science ®Google Scholar
• Sundaram SM, Chung L. An update on systemic sclerosis-associated pulmonary arterial hypertension: a review of the current literature. Curr Rheumatol Rep. 2018;20(2):10.
   PubMed Web of Science ®Google Scholar
• Mazurek JA, Horne BD, Saeed W, et al. Galectin-3 levels are elevated and predictive of mortality in pulmonary hypertension. Hear Lung Circ. 2017;26(11):1208–1215.
   PubMed Web of Science ®Google Scholar
• Shen Q, Chen W, Liu J, et al. Galectin-3 aggravates pulmonary arterial hypertension via immunomodulation in congenital heart disease. Life Sci. 2019;232:116546.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang Y, Zhang J, et al. Galectin-3 contributes to vascular fibrosis in monocrotaline-induced pulmonary arterial hypertension rat model. J Biochem Mol Toxicol. 2017;31(5):e21879.
   Web of Science ®Google Scholar
• Barman SA, Li X, Haigh S, et al. Galectin-3 is expressed in vascular smooth muscle cells and promotes pulmonary hypertension through changes in proliferation, apoptosis, and fibrosis. Am J Physiol Lung Cell Mol Physiol. 2019;316(5):L784–L797.
   PubMed Web of Science ®Google Scholar
• Li T, Zha L, Luo H, et al. Galectin-3 mediates endothelial-to-mesenchymal transition in pulmonary arterial hypertension. Aging Dis. 2019;10(4):731–745.
   PubMed Web of Science ®Google Scholar
• Luo H, Liu B, Zhao L, et al. Galectin-3 mediates pulmonary vascular remodeling in hypoxia-induced pulmonary arterial hypertension. J Am Soc Hypertens. 2017;11(10):673–683.e3.
   PubMed Web of Science ®Google Scholar
• Maldonado CA, Sundblad V, Salatino M, et al. Cell-type specific regulation of galectin-3 expression by glucocorticoids in lung Clara cells and macrophages. Histol Histopathol. 2011;26(6):747–759.
   PubMed Web of Science ®Google Scholar
• Stochmal A, Czuwara J, Zaremba M, et al. Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis. Arch Dermatol Res. 2020;312(6):453–458.
   PubMed Web of Science ®Google Scholar
• Li L, Li J, Gao J. Functions of galectin-3 and its role in fibrotic diseases. J Pharmacol Exp Ther. 2014;351(2):336–343.
   PubMed Web of Science ®Google Scholar
• Amin HZ, Amin LZ, Wijaya IP. Galectin-3: a novel biomarker for the prognosis of heart failure. Clujul Med. 2017;90(2):129–132. 
   PubMedGoogle Scholar